FTI Consulting, Inc.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: US3029411093
USD
166.66
1.63 (0.99%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About FTI Consulting, Inc. stock-summary
stock-summary
FTI Consulting, Inc.
Miscellaneous
FTI Consulting, Inc. is a business advisory company. The Company operates through five segments: Corporate Finance & Restructuring, Forensic and Litigation Consulting, Economic Consulting, Technology and Strategic Communications. The Company provides advice and services, such as restructuring (including bankruptcy), capital formation and indebtedness, interim business management, performance improvements, forensic accounting and litigation matters, international arbitrations, mergers and acquisitions (M&A), antitrust and competition matters, securities litigation, electronic discovery (or e-discovery), management and retrieval of electronically stored information (ESI), reputation management and strategic communications. The Company collaborates with Chief Financial Officers (CFOs) and their finance and accounting organizations and uses engagement tools to provide transformation services, manage risk, deliver business intelligence capabilities, and prepare for and execute events.
Company Coordinates stock-summary
Company Details
555 12th St NW , WASHINGTON DC : 20004-1200
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 102 Schemes (44.4%)

Foreign Institutions

Held by 177 Foreign Institutions (24.9%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Gerard Holthaus
Independent Chairman of the board
Mr. Steven Gunby
President, Chief Executive Officer, Director
Ms. Brenda Bacon
Independent Director
Mr. Mark Bartlett
Independent Director
Dr. Claudio Costamagna
Independent Director
Sir Vernon Ellis
Independent Director
Mr. Nicholas Fanandakis
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
944 Million
(Quarterly Results - Jun 2025)
Net Profit:
72 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 5,405 Million (Small Cap)

stock-summary
P/E

20.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.19

stock-summary
Return on Equity

14.52%

stock-summary
Price to Book

2.85